>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
老年非小细胞肺癌手术前后应用普米克令舒及沐舒坦雾化吸入的临床观察
作者:陈霞1  林星宇2  刘沫3 
单位:1. 辽宁医学院研究生学院, 辽宁 锦州 121001;
2. 吉林大学第一医院, 吉林 长春 130000;
3. 辽宁医学院附属第一医院, 辽宁 锦州 121001
关键词:普米克令舒 雾化吸入 肺癌 老年患者 
分类号:R459.1
出版年·卷·期(页码):2013·32·第五期(594-598)
摘要:

目的:观察老年非小细胞肺癌手术前后应用普米克令舒、沐舒坦雾化吸入对临床指标的影响,进一步探讨大剂量普米克令舒雾化吸入的临床疗效。方法:将90例接受开胸手术的老年非小细胞肺癌患者随机分为3组,在常规治疗基础上,于术前3 d和术后3 d观察1组予生理盐水10 ml+沐舒坦30 mg+普米克令舒1 mg、观察2组予生理盐水10 ml +沐舒坦30 mg +普米克令舒2 mg、对照组予生理盐水10 ml+沐舒坦30 mg雾化吸入,每天3次。比较3组之间PaCO2、PaO2、SaO2、痰量、痰液pH值、术后住院天数、平均术后带管天数、术后体温、白细胞计数、中性粒细胞绝对值和中性粒细胞百分比、术后并发症等指标。结果:3组之间上述指标中除SaO2差异无统计学意义外,其余指标差异均有统计学意义(P<0.01)。与对照组比较,观察组临床指标明显改善,其中观察2组临床指标改善更显著。结论:老年非小细胞肺癌手术前后应用大剂量普米克令舒联合沐舒坦雾化吸入对减轻肺部炎症具有较好的效果。

Objective: To observe the affect on clinical indicators of Pulmicort combined with Mucosolvan atomizing inhalation before and after surgery in elderly patients with non-small cell lung cancer and to further explore the clinical efficacy of large dose Pulmicort aerosol inhalation. Methods: Ninety elderly patients with non-small cell lung cancer who underwent thoracotomy surgery were randomly divided into three groups and on the basis of routine treatment,the observation group 1 was given saline 10 ml+Mucosolvan 30 mg+Pulmicort 1 mg, the observation group 2 was given saline 10 ml +Mucosolvan 30 mg+Pulmicort 2 mg, the control group was given saline 10 ml+Mucosolvan 30 mg inhalation three times a day, at three days before and after surgery, PaCO2,PaO2,SaO2, sputum volume, sputum pH value, postoperative hospital stay days, the average postoperative days with pipe, postoperative body temperature, white blood cell values, absolute neutrophil count and neutrophil percentage, postoperative complications were compared among the three groups. Results: In addition to SaO2,the rest indicators among the three groups had significantly differences(P<0.01).Compared with the control group, clinical indica-tors of the observation group had improved significantly and the observation groups 2 improved more significantly. Conclusion: Application of large dose of Pulmicort combined with Mucosolvan aerosol inhalation in elderly patients with non small cell lung cancer before and after operation has better effect of reducing inflammation of the lungs.

参考文献:

[1] 谢春玲,王丽华,伦雪萍,等.改良雾化吸入喷喉方预防肺癌术后肺部并发症高危患者的效果观察[J].齐齐哈尔医学院学报,2011,32(13):2179-2180.
[2] De RIJKE J M,SCHOUTEN L J,Ten VELDE G P,et al.Influence of age,comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer:results of a population-based study[J].Lung Cancer,2004,46(2):233-245.
[3] ALGAR F J,ALVAREZ A,SALVATIERRA A,et al.Predict pulmonary complications after pneumonectomy for lung cancer[J].Eur J Cardiothorac Surg,2003,23:201-208.
[4] 赵守华,刘向阳,张德超,等.70岁以上老年肺癌患者术后严重并发症和死亡危险因素分析[J].中华老年医学杂志,2006,25:660-663.
[5] 冯艳红,陆重琳,朱小云,等.a-干扰素雾化吸入预防老年呼吸道感染[J].东南大学学报:医学版,2006,25(2):120-121.
[6] STEPHAN F,BOUCHESEICHE S,HOLLANDE J,et al.Pulmonary complications following lung resection:a comprehensive analysis of incidence and possible risk factors[J].Chest,2000,118:1263-1270.
[7] SUEMITSU R,TAKEO S,HAMATAKE M,et al.The perioperative complications for elderly patients with lung cancer associated with a pulmonary resection under general anesthesia[J].J Thorac Oncol,2009,4:193-197.
[8] 朱毅,孙培莉.激素联合支气管舒张剂雾化吸入治疗哮喘中重度急性发作疗效评价[J].东南大学学报:医学版,2011,30(6):882-885.
[9] 李焕琼.不同剂量普米克令舒联合异丙托溴铵治疗毛细支气管炎的疗效观察[J].中国当代医药,2012,19(18):85-86.
[10] 李建领,吴鸿雁,王来成.普米克令舒联合喘乐宁与双倍剂量普米克令舒气泵雾化吸入治疗儿童哮喘轻-中度发作的疗效观察[J].中华实用诊断与治疗杂志,2009,4(2):381-382.
[11] 林青,曾芳,李媛.特布他林联合普米克令舒雾化吸入治疗慢性阻塞性肺疾病急性加重期的临床观察[J].中国现代药物应用,2012,6(7):15-16.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 413731 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364